{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:42:13Z","timestamp":1761561733403},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,3,14]],"date-time":"2013-03-14T00:00:00Z","timestamp":1363219200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s40264-013-0024-z","type":"journal-article","created":{"date-parts":[[2013,3,13]],"date-time":"2013-03-13T11:41:24Z","timestamp":1363174884000},"page":"435-439","source":"Crossref","is-referenced-by-count":19,"title":["The Effects of Antitussive Treatment of ACE Inhibitor-Induced Cough on Therapy Compliance: A Prescription Sequence Symmetry Analysis"],"prefix":"10.1007","volume":"36","author":[{"given":"Stefan","family":"Vegter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pieter","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaas Willem","family":"van Dijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sipke","family":"Visser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lolkje T. W.","family":"de Jong-van den Berg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,3,14]]},"reference":[{"issue":"11","key":"24_CR1","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/eurheartj\/ehp103","volume":"30","author":"JJ Brugts","year":"2009","unstructured":"Brugts JJ, Ninomiya T, Boersma E, Remme WJ, Bertrand M, Ferrari R, et al. The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials. Eur Heart J. 2009;30(11):1385\u201394.","journal-title":"Eur Heart J"},{"issue":"19","key":"24_CR2","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1056\/NEJMoa042167","volume":"351","author":"P Ruggenenti","year":"2004","unstructured":"Ruggenenti P, Fassi A, Ilieva AP, Bruno S, Iliev IP, Brusegan V, et al. Preventing microalbuminuria in type 2 diabetes. N Engl J Med. 2004;351(19):1941\u201351.","journal-title":"N Engl J Med"},{"issue":"9176","key":"24_CR3","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0140-6736(98)10363-X","volume":"354","author":"P Ruggenenti","year":"1999","unstructured":"Ruggenenti P, Perna A, Gherardi G, Garini G, Zoccali C, Salvadori M, et al. Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria. Lancet. 1999;354(9176):359\u201364.","journal-title":"Lancet"},{"issue":"1","key":"24_CR4","doi-asserted-by":"crossref","first-page":"72","DOI":"10.2165\/00002018-199615010-00006","volume":"15","author":"A Overlack","year":"1996","unstructured":"Overlack A. ACE inhibitor-induced cough and bronchospasm. Incidence, mechanisms and management. Drug Saf. 1996;15(1):72\u20138.","journal-title":"Drug Saf"},{"issue":"3","key":"24_CR5","doi-asserted-by":"crossref","first-page":"234","DOI":"10.7326\/0003-4819-117-3-234","volume":"117","author":"ZH Israili","year":"1992","unstructured":"Israili ZH, Hall WD. Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology. Ann Intern Med. 1992;117(3):234\u201342.","journal-title":"Ann Intern Med"},{"issue":"12","key":"24_CR6","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1001\/archinte.1989.00390120061012","volume":"149","author":"GR Gibson","year":"1989","unstructured":"Gibson GR. Enalapril-induced cough. Arch Intern Med. 1989;149(12):2701\u20133.","journal-title":"Arch Intern Med"},{"issue":"11","key":"24_CR7","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/ajh\/7.11.1012","volume":"7","author":"I Os","year":"1994","unstructured":"Os I, Bratland B, Dahlof B, Gisholt K, Syvertsen JO, Tretli S. Female preponderance for lisinopril-induced cough in hypertension. Am J Hypertens. 1994;7(11):1012\u20135.","journal-title":"Am J Hypertens"},{"key":"24_CR8","doi-asserted-by":"crossref","unstructured":"Morimoto T, Gandhi TK, Fiskio JM, Seger AC, So JW, Cook EF, et al. An evaluation of risk factors for adverse drug events associated with angiotensin-converting enzyme inhibitors. J Eval Clin Pract. 2004;10(4):499\u2013509.","DOI":"10.1111\/j.1365-2753.2003.00484.x"},{"issue":"10","key":"24_CR9","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1136\/thorax.58.10.901","volume":"58","author":"AH Morice","year":"2003","unstructured":"Morice AH, Kastelik JA. Cough. 1: chronic cough in adults. Thorax. 2003;58(10):901\u20137.","journal-title":"Thorax"},{"issue":"9621","key":"24_CR10","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0140-6736(08)60596-6","volume":"371","author":"ID Pavord","year":"2008","unstructured":"Pavord ID, Chung KF. Management of chronic cough. Lancet. 2008;371(9621):1375\u201384.","journal-title":"Lancet"},{"issue":"1 Suppl","key":"24_CR11","doi-asserted-by":"crossref","first-page":"169S","DOI":"10.1378\/chest.129.1_suppl.169S","volume":"129","author":"PV Dicpinigaitis","year":"2006","unstructured":"Dicpinigaitis PV. Angiotensin-converting enzyme inhibitor-induced cough: ACCP evidence-based clinical practice guidelines. Chest. 2006;129(1 Suppl):169S\u201373S.","journal-title":"Chest"},{"issue":"2","key":"24_CR12","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1378\/chest.128.2.976","volume":"128","author":"C Lombardi","year":"2005","unstructured":"Lombardi C, Crivellaro M, Dama A, Senna G, Gargioni S, Passalacqua G. Are physicians aware of the side effects of angiotensin-converting enzyme inhibitors?: a questionnaire survey in different medical categories. Chest. 2005;128(2):976\u20139.","journal-title":"Chest"},{"issue":"2","key":"24_CR13","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1365-2125.2009.03571.x","volume":"69","author":"S Vegter","year":"2010","unstructured":"Vegter S. de Jong-van den Berg LT. Misdiagnosis and mistreatment of a common side-effect\u2013angiotensin-converting enzyme inhibitor-induced cough. Br J Clin Pharmacol. 2010;69(2):200\u20133.","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"24_CR14","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1001\/archfami.4.6.525","volume":"4","author":"CG Olsen","year":"1995","unstructured":"Olsen CG. Delay of diagnosis and empiric treatment of angiotensin-converting enzyme inhibitor-induced cough in office practice. Arch Fam Med. 1995;4(6):525\u20138.","journal-title":"Arch Fam Med"},{"issue":"6","key":"24_CR15","doi-asserted-by":"crossref","first-page":"162","DOI":"10.18773\/austprescr.2011.084","volume":"34","author":"LM Kalisch","year":"2011","unstructured":"Kalisch LM, Caughey GE, Roughead EE. The prescribing cascade. Aust Prescr. 2011;34(6):162\u20136.","journal-title":"Aust Prescr"},{"issue":"7115","key":"24_CR16","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1136\/bmj.315.7115.1096","volume":"315","author":"PA Rochon","year":"1997","unstructured":"Rochon PA, Gurwitz JH. Optimising drug treatment for elderly people: the prescribing cascade. BMJ. 1997;315(7115):1096\u20139.","journal-title":"BMJ"},{"key":"24_CR17","doi-asserted-by":"crossref","unstructured":"Wallenius SH, Vainio KK, Korhonen MJ, Hartzema AG, Enlund HK. Self-initiated modification of hypertension treatment in response to perceived problems. Ann Pharmacother. 1995;29(12):1213\u201317.","DOI":"10.1177\/106002809502901204"},{"key":"24_CR18","doi-asserted-by":"crossref","unstructured":"Schirm E, Monster TB, de Vries R, van den Berg PB, de Jong-van den Berg LT, Tobi H. How to estimate the population that is covered by community pharmacies? An evaluation of two methods using drug utilisation information. Pharmacoepidemiol Drug Saf. 2004;13(3):173\u20139.","DOI":"10.1002\/pds.882"},{"key":"24_CR19","doi-asserted-by":"crossref","unstructured":"Tobi H, van den Berg PB, de Jong-van den Berg LT. The interaction database: synergy of science and practice in pharmacy. In: Brause RW, Hanisch E, editors. Medical data analysis. Berlin: Springer; 2000. p. 206\u201311.","DOI":"10.1007\/3-540-39949-6_25"},{"key":"24_CR20","first-page":"347","volume-title":"Pharmacoepidemiology","author":"HGM Leufkens","year":"2008","unstructured":"Leufkens HGM, Urquhart J. Automated pharmacy record linkage in the Netherlands. In: Strom BL, editor. Pharmacoepidemiology. Chichester: Wiley; 2008. p. 347\u201360."},{"issue":"5","key":"24_CR21","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/00001648-199609000-00004","volume":"7","author":"J Hallas","year":"1996","unstructured":"Hallas J. Evidence of depression provoked by cardiovascular medication: a prescription sequence symmetry analysis. Epidemiology. 1996;7(5):478\u201384.","journal-title":"Epidemiology"},{"key":"24_CR22","doi-asserted-by":"crossref","unstructured":"Cramer JA, Roy A, Burrell A, Fairchild CJ, Fuldeore MJ, Ollendorf DA, et al. Medication compliance and persistence: terminology and definitions. Value Health. 2008;11(1):44\u20137.","DOI":"10.1111\/j.1524-4733.2007.00213.x"},{"key":"24_CR23","unstructured":"Vegter S, Nguyen NH, Visser ST, de Jong-van den Berg LT, Postma MJ, Boersma C. Compliance, persistence, and switching patterns for ACE inhibitors and ARBs. Am J Manag Care. 2011;17(9):609\u201316."},{"key":"24_CR24","doi-asserted-by":"crossref","unstructured":"Amin AP, Mukhopadhyay E, Nathan S, Napan S, Kelly RF. Association of medical noncompliance and long-term adverse outcomes, after myocardial infarction in a minority and uninsured population. Transl Res. 2009;154(2):78\u201389.","DOI":"10.1016\/j.trsl.2009.05.004"},{"key":"24_CR25","doi-asserted-by":"crossref","unstructured":"Ho PM, Magid DJ, Shetterly SM, Olson KL, Maddox TM, Peterson PN, et al. Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. Am Heart J. 2008;155(4):772\u20139.","DOI":"10.1016\/j.ahj.2007.12.011"},{"issue":"5","key":"24_CR26","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1177\/1352458505070618","volume":"12","author":"DT Wade","year":"2006","unstructured":"Wade DT, Makela PM, House H, Bateman C, Robson P. Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis. Mult Scler. 2006;12(5):639\u201345.","journal-title":"Mult Scler"},{"key":"24_CR27","doi-asserted-by":"crossref","unstructured":"Karve S, Cleves MA, Helm M, Hudson TJ, West DS, Martin BC. Good and poor adherence: optimal cut-point for adherence measures using administrative claims data. Curr Med Res Opin. 2009;25(9):2303\u201310.","DOI":"10.1185\/03007990903126833"},{"key":"24_CR28","doi-asserted-by":"crossref","unstructured":"B\u00f6hm M, Baumh\u00e4kel M, Mahfoud F, Werner C. From evidence to rationale: cardiovascular protection by angiotensin II receptor blockers compared with angiotensin-converting enzyme inhibitors. Cardiology. 2010;117(3):163\u201373.","DOI":"10.1159\/000320094"}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-013-0024-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40264-013-0024-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-013-0024-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T19:41:28Z","timestamp":1559504488000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40264-013-0024-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,14]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["24"],"URL":"https:\/\/doi.org\/10.1007\/s40264-013-0024-z","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,14]]}}}